Pharmacological antiemetic prophylaxis and treatment for opioid-induced nausea and vomiting (OINV) in patients treated for cancer pain and cancer-related breathlessness
- PMID: 40878845
- PMCID: PMC12395543
- DOI: 10.1002/14651858.CD016207
Pharmacological antiemetic prophylaxis and treatment for opioid-induced nausea and vomiting (OINV) in patients treated for cancer pain and cancer-related breathlessness
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of pharmacological treatments given prophylactically or on-demand after onset of opioid-induced nausea and vomiting (OINV) in people being treated for cancer pain or cancer dyspnoea, when compared to placebo or other pharmacological interventions.
Copyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.
Conflict of interest statement
JG: no commercial or non‐commercial conflicts of interest relevant to this review. He is a specialist palliative care physician and manages palliative care patients.
CAH: no commercial or non‐commercial conflicts of interest relevant to this review. He works as a medical information specialist.
VP: no commercial or non‐commercial conflicts of interest relevant to this review.
GS: received personal consulting fees for 'External statistical consultant of Roche Pharma AG, Grenzach‐Wyhlen, Germany'
CR: no commercial or non‐commercial conflicts of interest relevant to this review. She is a pharmacist leading the Competence Centre for Palliative Pharmacy.
KS: no commercial or non‐commercial conflicts of interest relevant to this review. She is a pharmacist and project manager.
CB: planned an investigator‐initiated study that is potentially eligible for inclusion [52]. Therefore, he will not make study eligibility decisions about this study; if it is included, he will not extract data from it, carry out the risk of bias assessment, or perform GRADE assessments for comparisons and outcomes that include this study (section 5.6 of Cochrane’s Conflict of Interest Policy). CB is a specialist palliative care physician and manages palliative care patients.
References
-
- Henson LA, Maddocks M, Evans C, Davidson M, Hicks S, Higginson IJ. Palliative care and the management of common distressing symptoms in advanced cancer: pain, breathlessness, nausea and vomiting, and fatigue. Journal of Clinical Oncology 2020;38(9):905-14. [DOI: 10.1200/JCO.19.00470] - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
